Health Trials

Stargardt

2

Review clinical trials related to Stargardt. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4

To evaluate the preliminary safety of monocular and single subretinal injection of ZVS106e injection in the treatment of patients with hereditary retinal degeneration (ABCA4-IRDS) caused by ABCA4 biallelic mutations.

Participants needed: 9
Trial details
Phase: Early Phase 1Age: 8+Biological sex: AllType: InterventionalSponsor: Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUpdated: Apr 16, 2026Locations: 2
Eligibility criteria

Age ≥8 years old; [+4]

The researchers determined that the target eye currently has or has previously h... [+10]

Read more
Status: Recruiting

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

This is an Observational Study to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene This is a multicenter study which will enroll approximately 75 subjects

Participants needed: 75
Trial details
Age: 12-65Biological sex: AllType: ObservationalSponsor: Splice BioUpdated: Sep 19, 2025Locations: 20
Eligibility criteria

Provide written consent [+9]

Are an immediate family member (e.g., child, sibling) of the Sponsor or study si... [+10]

Read more